ASC Therapeutics
PrivateCompany Overview
ASC Therapeutics operates in Healthcare & Life Sciences and is based in Milpitas, California. It was founded in 2019.
ASC Therapeutics is a biotechnology company that develops gene replacement, gene editing, and allogeneic cell therapies for hematological, metabolic, and other rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ASC Therapeutics Comparables
Compare ASC Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sangamo Therapeutics Inc | 83% | |
| Expression Therapeutics, Inc. | 81% | |
| Ultragenyx Pharmaceutical Inc. | 79% |
For institutional investors. Book with your work email.
ASC Therapeutics Funding Rounds
Historical fundraising activity
ASC Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ASC Therapeutics's valuation, stock price, and market status.
Is ASC Therapeutics a public or private company?
ASC Therapeutics is a private company.
What is the current stock price of ASC Therapeutics?
ASC Therapeutics is a private company, so its shares have no public market price. Caplight tracks ASC Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ASC Therapeutics worth (valuation)?
Valuation information for ASC Therapeutics is not publicly available.
Can I buy ASC Therapeutics stock?
ASC Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ASC Therapeutics's last funding round?
Funding round information for ASC Therapeutics is not publicly available.
Who are the main investors in ASC Therapeutics?
Investor information for ASC Therapeutics is not publicly disclosed.
Will ASC Therapeutics IPO soon?
No public IPO plans have been announced for ASC Therapeutics.
How can I track ASC Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in ASC Therapeutics's shares on secondary markets.